Wealth Management Partners »

Summit Therapeutics shares owned by Wealth Management Partners

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Wealth Management Partners from 13F filings

Historical chart of Wealth Management Partners investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Wealth Management Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Wealth Management Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.9M 88k 21.90
2024-06-30 $328k 42k 7.80
2024-03-31 $182k 44k 4.14
2023-12-31 $39k 15k 2.61

More positions owned by Wealth Management Partners

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Gold Tr Ishares New (IAU)
Microsoft Corporation (MSFT)
First Tr Exchange-traded Dj Internt Idx (FDN)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
Amazon (AMZN)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr Core S&p Us Vlu (IUSV)
Tesla Motors (TSLA)
Exxon Mobil Corporation (XOM)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)

View all positions for Wealth Management Partners

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
BlackRock
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Jane Street
Susquehanna International
Citadel Advisors
Charles Schwab Investment Management
Standard Life Aberdeen
Darwin Global Management
Balyasny Asset Management
Northern Trust

View all funds holding Summit Therapeutics